TE Connectivity announces third quarter results for fiscal year 2024
Delivered EPS above guidance driven by strong margin expansion; Record year-to-date cash flow SCHAFFHAUSEN, Switzerland, July 24, 2024 /PRNewswire/ --...
Day: July 24, 2024
Cosmos Health Updates on Contract Manufacturing Division; Completes Phase I of Production Capacity Expansion, Positioned to Generate Over $10M in Annual Gross Profit at Full Capacity
CHICAGO, IL / ACCESSWIRE / July 24, 2024 / Cosmos Health Inc. ("Cosmos Health" or the "Company'') (NASDAQ:COSM), a diversified,...
SimplyHome Launches Innovative Remote DSP Service to Transform Long-Term Support Solutions (LTSS)
Long-standing enabling technology provider introduces a remote Direct Support Professional solution, combining cutting-edge technology with compassionate, accessible careARDEN, NC /...
NBA Athlete Ben Sheppard From the Indiana Pacers Launches Exciting Business Partnership With Earth’s Splendor Vitamin and Supplement Brand
This new partnership reflects Ben's commitment to his physical and mental fitness, prioritizing peak performance and overall wellness as he...
CBDL’s Recent Additions to Active Sales Channels Fuel 18-Month Sales Projections; CBD Vault(TM) Products’ Projected 2025 Sales Revenues to Reach $1.8 Million
SCOTTSDALE, AZ / ACCESSWIRE / July 24, 2024 / CBD Life Sciences Inc. (OTC PINK:CBDL), including its wholly-owned subsidiary, The...
Beyond “One Bug, One Drug” – Tonix Pharmaceuticals Secures Up To $34 Million In Funding From The U.S. Department Of Defense To Develop a Broad-Spectrum Antiviral
CHATHAM, NJ / ACCESSWIRE / July 24, 2024 / From anthrax to the plague, biological warfare is a real threat...
Custom Health Celebrates the Launch of the Opioid Addiction Deterrence Task Force (OADTF) by the American Medical Technology Coalition
CEO of Custom Health and Executive Director of the American Medical Technology Coalition Shane Bishop announced the launch of the...
COVID is Here to Stay and NV-387 is a Much Needed Drug Against It, Reminds NanoViricides
SHELTON, CT / ACCESSWIRE / July 24, 2024 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical stage global leader...
The Broken Brown Egg and Progyny Announce the 2024 Awareness, Hope, and Activism Grant™ to Support BIPOC Individuals and Couples in Family Building
NEW YORK, July 24, 2024 (GLOBE NEWSWIRE) -- Progyny, Inc (Nasdaq: PGNY), a transformative fertility, family building, and women’s health...
AIM Announces New Positive Data on Ampligen’s Anti-Tumor Potential When Used as Part of a Combination Therapy
OCALA, Fla., July 24, 2024 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) today announced the...
Revolo Announces New Data Further Validating the Upstream Mechanism of Action and Subcutaneous Administration of ‘1104
Reduction of key proteins in the interleukin 4 (IL-4) and IL-13 signalling pathway via SHP-1 activation is a key component...
Scorpius Holdings Set to Launch First Mammalian cGMP Campaign at San Antonio Facility in the 2024 3rd Quarter
DURHAM, N.C., July 24, 2024 (GLOBE NEWSWIRE) -- Scorpius Holdings, Inc. (NYSE American: SCPX), (“Scorpius” or the “Company”), an integrated...
Intelligent Bio Solutions Inc. Announces QabasTech as Exclusive Distributor in Saudi Arabia
NEW YORK, July 24, 2024 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical...
TOMI Environmental Solutions Secures $1.2 Million Contract with Enviro-Mist Inc. Driving SteraMist Growth in the Pharmaceutical Market
FREDERICK, Md., July 24, 2024 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc.® (“TOMI”) (NASDAQ: TOMZ), a global company specializing in...
ICU Medical Announces Time of Second Quarter 2024 Earnings Conference Call
SAN CLEMENTE, Calif., July 24, 2024 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq: ICUI), a leader in the development, manufacture...
MangoRx Initiates Efficacy Studies on its Patented Respiratory Illness Prevention Technology
Dallas, Texas, July 24, 2024 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ: MGRX) (“MangoRx” or the “Company”), a leader in men’s...
Catalyst Pharmaceuticals Enters Into an Exclusive License, Supply and Commercialization Agreement with Kye Pharmaceuticals for AGAMREE® in Canada
CORAL GABLES, Fla., July 24, 2024 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst" or "Company") (Nasdaq: CPRX), a commercial-stage biopharmaceutical company...
R1 RCM Special Committee Provides Update on Evaluation of Strategic Alternatives
Sets Final Bid Deadline of July 31, 2024MURRAY, Utah, July 24, 2024 (GLOBE NEWSWIRE) -- The Special Committee of the...
Intra-Cellular Therapies to Host Second Quarter 2024 Financial Results Conference Call and Webcast
NEW YORK, July 24, 2024 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq: ITCI), a biopharmaceutical company focused on the development and...
ImPact Biotech Receives a €13.5M Investment Commitment from the European Innovation Council’s Accelerator Program
TEL AVIV, Israel, July 24, 2024 (GLOBE NEWSWIRE) -- ImPact Biotech, a clinical-stage biotechnology company focused on developing Padeliporfin vascular...